Type 1 Diabetes: BTNL2‐Ig Protein Attenuates Type 1 Diabetes in Non‐Obese Diabetic (NOD) Mice (Adv. Healthcare Mater. 9/2019)

Advanced healthcare materials - United Kingdom
doi 10.1002/adhm.201970038
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-Obese Diabetic Mice

Frontiers in Immunology
AllergyImmunology
2019English

Masthead: (Adv. Healthcare Mater. 1/2019)

Advanced healthcare materials
Biomedical EngineeringBiomaterialsPharmaceutical Science
2019English

Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Echinochrome Pigment Attenuates Diabetic Nephropathy in the Models of Type 1 and Type 2 Diabetes

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Manipulation of CD98 Resolves Type 1 Diabetes in Nonobese Diabetic Mice

Journal of Immunology
AllergyImmunology
2012English

TRIF Deficiency Protects Non-Obese Diabetic Mice From Type 1 Diabetes by Modulating the Gut Microbiota and Dendritic Cells

Journal of Autoimmunity
AllergyImmunology
2018English

The Anti-Inflammatory Compound Lisofylline Prevents Type I Diabetes in Non-Obese Diabetic Mice

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

NOD Mice With High Incidence of Type 1 Diabetes Are Not T Lymphocytopenic.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1988English

Masthead: (Adv. Healthcare Mater. 9/2019)

Advanced healthcare materials
Biomedical EngineeringBiomaterialsPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy